ivanqukeafelovo.blogspot.com
Howes, who also will serve as vice presidenyt forcorporate development, joins Akebias from Serenex. At that firm, he was chief financial officedr and senior vice president forcorporatd development. “We are extremely pleased to have Ianjoin Akebia. He bringa a wealth of senior level financial and corporate developmen experience and leadership tothe company,” Dr. Josepj Gardner, CEO of Akebia, said in a presz release. “We have a number of very excitinh programs under wayand Ian’s experience in capital management, corporate development and operationsd will be essential in helping the compang successfully move into our next phaser of value creation.” At Durham, N.C.
-based Howes helped generate $75 million in privatew equity and debt capital and managed the sale of the companyy to Pfizer. Before that, he was chief financiaol officer atParadigm Genetics. “Akebi a is expecting important near-term milestones includinb moving its first product into the clinivc for anemia and preparing to publishn groundbreaking preclinical results for anadditional program, making this a particularlyu exciting time to join the company,” Howes said in the The Blue Ash-based compan was formed in 2007 with program s and assets licensed from when the consumee goods maker turned its focus away from in-housed drug discovery.
Cincinnati-based was one of the original
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment